These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra. Dentresangle C; Le Cavorsin M; Savasta M; Leviel V Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005 [TBL] [Abstract][Full Text] [Related]
65. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. Oiwa Y; Sanchez-Pernaute R; Harvey-White J; Bankiewicz KS J Neurosurg; 2003 Jan; 98(1):136-44. PubMed ID: 12546362 [TBL] [Abstract][Full Text] [Related]
66. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats. Geula C; Slevin JT Synapse; 1989; 4(3):248-53. PubMed ID: 2532792 [TBL] [Abstract][Full Text] [Related]
67. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice. Liu B; Dluzen DE Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530 [TBL] [Abstract][Full Text] [Related]
68. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice]. Date I; Asari S; Nishimoto A; Felten DL No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347 [TBL] [Abstract][Full Text] [Related]
69. Experimental change on dopaminergic neurons in striatum of Parkinson disease rats. Chen XY; Li J; Qi WQ; Shen SH Histol Histopathol; 2007 Oct; 22(10):1085-90. PubMed ID: 17616935 [TBL] [Abstract][Full Text] [Related]
70. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model. Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587 [TBL] [Abstract][Full Text] [Related]
71. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. Snyder GL; Keller RW; Zigmond MJ J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978 [TBL] [Abstract][Full Text] [Related]
72. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Chung CY; Koprich JB; Hallett PJ; Isacson O Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22474-9. PubMed ID: 20007772 [TBL] [Abstract][Full Text] [Related]
73. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats. Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100 [TBL] [Abstract][Full Text] [Related]
74. Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolism. Wesemann W; Solbach M; Nafe R; Grote C; Sontag KH; Riederer P; Jellinger K; Mennel HD; Clement HW J Neural Transm Suppl; 1995; 46():175-82. PubMed ID: 8821053 [TBL] [Abstract][Full Text] [Related]
75. Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease. Sullivan AM; Opacka-Juffry J; Hötten G; Pohl J; Blunt SB Neurosci Lett; 1997 Sep; 233(2-3):73-6. PubMed ID: 9350835 [TBL] [Abstract][Full Text] [Related]
76. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra. Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756 [TBL] [Abstract][Full Text] [Related]
77. Unilateral destruction of dopamine pathways increases ipsilateral striatal serotonin turnover in rats. Karstaedt PJ; Kerasidis H; Pincus JH; Meloni R; Graham J; Gale K Exp Neurol; 1994 Mar; 126(1):25-30. PubMed ID: 7512513 [TBL] [Abstract][Full Text] [Related]
78. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. Gajjar TM; Anderson LI; Dluzen DE J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187 [TBL] [Abstract][Full Text] [Related]
79. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats. Joo WS; Jin BK; Park CW; Maeng SH; Kim YS Neuroreport; 1998 Dec; 9(18):4123-6. PubMed ID: 9926859 [TBL] [Abstract][Full Text] [Related]
80. Neuroprotection by crocetin in a hemi-parkinsonian rat model. Ahmad AS; Ansari MA; Ahmad M; Saleem S; Yousuf S; Hoda MN; Islam F Pharmacol Biochem Behav; 2005 Aug; 81(4):805-13. PubMed ID: 16005057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]